Invention Grant
- Patent Title: Oxyntomodulin peptide analogue
- Patent Title (中): 胃泌酸调节蛋白肽类似物
-
Application No.: US12968382Application Date: 2010-12-15
-
Publication No.: US08367607B2Publication Date: 2013-02-05
- Inventor: Jorge Alsina-Fernandez , Wayne David Kohn
- Applicant: Jorge Alsina-Fernandez , Wayne David Kohn
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Andrea M Castetter
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K38/26 ; A61K38/28 ; A61P3/10 ; A61P7/12 ; C07K14/605 ; C07K5/00 ; C07K7/00 ; C07K16/00 ; C07K17/00
Abstract:
The present invention provides an Oxyntomodulin peptide analogue useful in the treatment of diabetes and/or obesity.
Public/Granted literature
- US20110152182A1 OXYNTOMODULIN PEPTIDE ANALOGUE Public/Granted day:2011-06-23
Information query
IPC分类:
